| 1 |
Pauletto PJT, Delgado CP, da Rocha JBT. Acid sphingomyelinase (ASM) and COVID-19: A review of the potential use of ASM inhibitors against SARS-CoV-2. Cell Biochem Funct 2023. [PMID: 36929117 DOI: 10.1002/cbf.3789] [Reference Citation Analysis]
|
| 2 |
Moccia F, Brunetti V, Perna A, Guerra G, Soda T, Berra-Romani R. The Molecular Heterogeneity of Store-Operated Ca(2+) Entry in Vascular Endothelial Cells: The Different roles of Orai1 and TRPC1/TRPC4 Channels in the Transition from Ca(2+)-Selective to Non-Selective Cation Currents. Int J Mol Sci 2023;24. [PMID: 36834672 DOI: 10.3390/ijms24043259] [Reference Citation Analysis]
|
| 3 |
Akanchise T, Angelova A. Potential of Nano-Antioxidants and Nanomedicine for Recovery from Neurological Disorders Linked to Long COVID Syndrome. Antioxidants (Basel) 2023;12. [PMID: 36829952 DOI: 10.3390/antiox12020393] [Reference Citation Analysis]
|
| 4 |
Susca N, Solimando AG, Borrelli P, Marziliano D, Monitillo F, Raimondo P, Vestito D, Lopizzo A, Brindicci G, Abumayyaleh M, El-Battrawy I, Saracino A, Grasso S, Brunetti ND, Racanelli V, Santoro F. Electrocardiographic Pathological Findings Caused by the SARS-CoV-2 Virus Infection: Evidence from a Retrospective Multicenter International Cohort Longitudinal Pilot Study of 548 Subjects. J Cardiovasc Dev Dis 2023;10. [PMID: 36826554 DOI: 10.3390/jcdd10020058] [Reference Citation Analysis]
|
| 5 |
Nejat R, Torshizi MF, Najafi DJ. S Protein, ACE2 and Host Cell Proteases in SARS-CoV-2 Cell Entry and Infectivity; Is Soluble ACE2 a Two Blade Sword? A Narrative Review. Vaccines (Basel) 2023;11. [PMID: 36851081 DOI: 10.3390/vaccines11020204] [Reference Citation Analysis]
|
| 6 |
Sasso EM, Muraki K, Eaton-fitch N, Smith P, Lesslar OL, Deed G, Marshall-gradisnik S. Transient receptor potential melastatin 3 dysfunction in post COVID-19 condition and myalgic encephalomyelitis/chronic fatigue syndrome patients. Mol Med 2022;28. [DOI: 10.1186/s10020-022-00528-y] [Reference Citation Analysis]
|
| 7 |
Iamartino L, Brandi ML. The calcium-sensing receptor in inflammation: Recent updates. Front Physiol 2022;13. [DOI: 10.3389/fphys.2022.1059369] [Reference Citation Analysis]
|
| 8 |
Milenina L, Krutetskaya Z, Antonov V, Krutetskaya N, Badulina V, Simonyan A. NEUROLEPTICS ATTENUATE Ca2+ RESPONSES INDUCED BY GLUTOXIM AND MOLIXAN IN MACROPHAGES. Russian Journal of Biological Physics and Chemisrty 2022;7:127-136. [DOI: 10.29039/rusjbpc.2022.0494] [Reference Citation Analysis]
|
| 9 |
Antonides LH, Hurst QW, Ives CM, Ramberg K, Ostrovitsa N, Scanlan E, Caffrey M, Pitt SJ, Zachariae U. The SARS-CoV-2 envelope (E) protein forms a calcium- and voltage-activated calcium channel.. [DOI: 10.1101/2022.10.11.511775] [Reference Citation Analysis]
|
| 10 |
de Antonellis P, Ferrucci V, Bibbo F, Asadzadeh F, Gorini F, Boccia A, Sorice C, Siciliano R, Russo R, Andolfo I, Lasorsa VA, Cantalupo S, Paolella G, Fusco G, Viscardi M, Brandi S, Pierri BM, Cerino P, Monaco V, choi D, Cheong J, Monti M, Iolascon A, Amente S, Capasso M, Kim H, Zollo M. Targeting ATP2B1 impairs PI3K/Akt/Fox-O3 signaling and reduces SARS-COV-2 replication in vivo.. [DOI: 10.1101/2022.09.02.22279542] [Reference Citation Analysis]
|
| 11 |
Sultan F, Ahuja K, Motiani RK. Potential of targeting host cell calcium dynamics to curtail SARS-CoV-2 infection and COVID-19 pathogenesis. Cell Calcium 2022;106:102637. [PMID: 35986958 DOI: 10.1016/j.ceca.2022.102637] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 12 |
di Filippo L, Frara S, Doga M, Giustina A. The osteo-metabolic phenotype of COVID-19: an update. Endocrine 2022. [PMID: 35857271 DOI: 10.1007/s12020-022-03135-3] [Reference Citation Analysis]
|
| 13 |
Lawal B, Kuo YC, Rachmawati Sumitra M, Wu ATH, Huang HS. Identification of a novel immune-inflammatory signature of COVID-19 infections, and evaluation of pharmacokinetics and therapeutic potential of RXn-02, a novel small-molecule derivative of quinolone. Comput Biol Med 2022;148:105814. [PMID: 35841781 DOI: 10.1016/j.compbiomed.2022.105814] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 14 |
Costa BTD, Araújo GRL, da Silva Júnior RT, Santos LKS, Lima de Souza Gonçalves V, Lima DBA, Cuzzuol BR, Santos Apolonio J, de Carvalho LS, Marques HS, Silva CS, Barcelos IS, Oliveira MV, Freire de Melo F. Effects of nutrients on immunomodulation in patients with severe COVID-19: Current knowledge. World J Crit Care Med 2022; 11(4): 201-218 [PMID: 36051942 DOI: 10.5492/wjccm.v11.i4.201] [Reference Citation Analysis]
|
| 15 |
Loas G, Van de Borne P, Darquennes G, Le Corre P. Association of Amlodipine with the Risk of In-Hospital Death in Patients with COVID-19 and Hypertension: A Reanalysis on 184 COVID-19 Patients with Hypertension. Pharmaceuticals (Basel) 2022;15. [PMID: 35337177 DOI: 10.3390/ph15030380] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
